期刊文献+

原发性中枢神经系统淋巴瘤16例临床分析及文献回顾

Sixteen cases with primary central nervous system lymphoma:clinical analysis with literature review
下载PDF
导出
摘要 目的探讨原发性中枢神经系统淋巴瘤(primary central nervous system lymphoma,PCNSL)的临床特点及诊治措施。方法总结我院1993年7月至2005年9月收治的16例免疫正常的PCNSL患者的临床资料。结果16例PCNSL,男11例,女5例,中位年龄52岁。就诊时主要临床表现为颅内压增高、偏瘫和癫痫,肿瘤多位于幕上的额顶颞叶。11例行手术,4例行立体定向活检,均给予放化疗,2000年1月以前的10例患者行VM-26+BCNU化疗,2000年1月以后的6例患者均给予大剂量甲氨蝶呤化疗。2000年以前的10例患者已全部死于肿瘤复发,中位生存期为16个月。2000年以后的6例患者已有3例死亡,中为生存期为29个月。结论原发性中枢神经系统淋巴瘤是一种恶性肿瘤,无特殊临床表现和影像学特征。颅内压增高为主要表现,大剂量甲氨蝶呤化疗联合放疗治疗PCNSL有效。 Objective We reported 16 cases of immunocompetent patients with primary central nervous system lymphoma (PCNSL) and analyzed its clinical characteristics, diagnosis and treatment. Methods Sixteen cases of immunocompetent patients with PCNSL admitted during 1993.7 to 2005.9 were included, Results There were 11 male and 5 female with median age of 52 years old. Symptoms included increase intracranial pressure, hemiparalysis and epilepsy. Most tumors were located at the frontal and temporoparietal regions. Eleven cases were operated, and 4 cases received stereotactic biopsy. All cases underwent radiotherapy and chemotherapy. Before 2000, 10 cases who received VM-26+BC-NU chemotherapy plus WBRT died. Their median survival time was 16 months. After 2000, 3 in 6 cases who received high-dose MTX chemotherapy plus WBRT died. Their median survival time was 29 months. Conclusions The clinical features and neuroimaging findings are nonspecific. Intracranial hypertension is the main clinical manifestation. High-dose MTX chemotherapy plus WBRT is effective for PCNSL.
作者 毕宏烨
机构地区 天津市人民医院
出处 《北京医学》 CAS 2007年第10期587-589,共3页 Beijing Medical Journal
关键词 中枢神经系统 淋巴瘤 放疗 化疗 Primary central nervous system Lymphoma Radiotherapy Chemotherapy
  • 相关文献

参考文献12

  • 1易基群,林桐榆,何友兼,黄慧强,夏忠军,夏云飞,徐瑞华,郭颖,管忠震.32例原发性中枢神经系统恶性淋巴瘤临床分析及文献复习[J].癌症,2006,25(4):476-480. 被引量:17
  • 2Alecio-Mattei T, Alecio-Mattei J, Aguiar PH, et al. Primary central nervous system lymphomas in immunocompetent patients. Neurocirugia, 2006, 17:46 - 53.
  • 3Basso U, Brandes AA. Diagnostic advances and new trends for the treatment primary central nervous system lymphoma. Eur J Cancer, 2002, 38:1298 - 1312.
  • 4Bataille B, Deiwail V, Menet E, et al. Primary intracerebral malignant lymphomas : report of 248 cases. J Neurosurg, 2000, 92 : 261 - 266.
  • 5Ishikawa H, Hasegawa M, Tamaki Y, et al.Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma. Jpn J Clin Oncol, 2003, 33:443 - 449.
  • 6Ferreri AJ, Reni M, Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol, 2000, 11:927 - 937.
  • 7Maher EA, Fine HA. Primary cNS lymphoma. Semin Oneol, 1999, 26:346 - 356.
  • 8Brada M, Dearnaley D, Horwich A, et al. Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radio therapy alone. Radiat Oncol Biol Phys, 1990, 18:787 - 792.
  • 9Mead GM, Bleehen NM, Gregor A, et al. A medical research council randomized trial in patients with primary cerebral nonHodgkin lymphoma:cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy. Cancer, 2000, 89:1359 - 1370.
  • 10Herrlinger V, Kuker W, Vhl M, et al . NDA-03 trial of high-dose methotrexate in primary central nervous system lymphoma:final report. Ann Neurol, 2005, 57:843 - 847.

二级参考文献14

  • 1胡毅,冯奉仪,石远凯,周立强,顾大中,王奇璐.原发性中枢神经系统淋巴瘤28例临床分析[J].中华肿瘤杂志,2004,26(6):375-378. 被引量:22
  • 2徐兵河 顾大中.中枢神经系统恶性淋巴瘤[A].王奇璐主编.恶性淋巴瘤的诊断与治疗[C].北京:北京医科大学中国协和医科大学联合出版社,1997.346.
  • 3Poortmans P M,Kluin-Nelemans H C,Haaxma-Reiche H,et al.High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma:European Organization for Research and Treatment of Cancer Lymphoma Group Phase Ⅱ Trial20962[J].J Clin Oncol,2003,21(24):4483-4488.
  • 4Batchelor T,Carson K,O'Neill A,et al.Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy:a report of NABTT 96-07[J].J Clin Oncol,2003,21 (6):1044-1049.
  • 5Bataille B,Delwail V,Menet E,et al.Primary intracerebeal malignant lymphoma:report of 248 cases[J].J Neuroesurg,2000,92 (2):261-266.
  • 6Basso U,Brandes A A.Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma[J].Eur J Cancer,2002,38(10):1298-1312.
  • 7Shenkier T N,Blay J Y,O'Neill B P,et al.Primary CNS lymphoma of T-cell origin:a descriptive analysis from the international primary CNS lymphoma collaborative group[J].J Clin Oncol,2005,23 (10):2233-2239.
  • 8Sacktor N.The epidemiology of human immunodeficiency virusassociated neurological disease in the era of highly active antiretroviral therapy[J].J Neurovirol,2002,8 (Suppl 2):115-121.
  • 9Ferreri A J,Reni M,Villa E.Therapeutic management of primary central nervous system lymphoma:lessons from prospective trials[J].Ann Oncol,2000,11 (8):927-937.
  • 10Schultz C,Scott C,Sherman W,et al.Preirradiation chemotherapy with cyclophosphamide,doxorubicin,vincristine,and dexamethasone for primary CNS lymphomas:initial report of Radiation Therapy Oncology Group Protocol 88-06[J].J Clin Oncol,1996,14(2):556-564.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部